GKB Ophthalmics
73.00
-1.85(-2.47%)
Market Cap₹36.77 Cr
PE Ratio-16.97
IndustryHealthcare
Company Performance:
1D-2.47%
1M+23.54%
6M+8.44%
1Y+11.42%
5Y-3.95%
View Company Insightsright
More news about GKB Ophthalmics
30Dec 25
GKB Ophthalmics Ltd Reports Insider Trading Disclosure Under SEBI Regulations
GKB Ophthalmics Ltd filed an insider trading disclosure with BSE regarding the purchase of 3,607 equity shares worth ₹2,14,003.07 by promoter group entity Krishna Gopal Gupta & Sons (HUF) between November 20-December 10, 2025. The disclosure was made under SEBI regulations as a corporate governance measure, despite the transaction being below prescribed thresholds.
 no imag found
26Nov 25
GKB Ophthalmics Shareholders Approve Voluntary Winding Up of Material Subsidiary GSV Ophthalmics
GKB Ophthalmics Limited shareholders approved the voluntary winding up of its material subsidiary, GSV Ophthalmics Private Limited, through a postal ballot on November 1, 2025. The special resolution for winding up passed with 99.87% votes in favor. However, shareholders rejected the ordinary resolution for prior approval of related party transactions worth Rs. 15.00 crores associated with the winding up process, with 76.52% votes against it. The e-voting period ran from October 3 to November 1, 2025, with 2,658 eligible shareholders.
 no imag found
20Nov 25
GKB Ophthalmics' Subsidiary GSV Ophthalmics Approves Voluntary Liquidation
The Board of Directors of GSV Ophthalmics Private Limited, a material subsidiary of GKB Ophthalmics, has approved voluntary liquidation under Section 59 of the Insolvency and Bankruptcy Code, 2016. This decision is subject to member approval. Mr. Manoj G. Nair has been appointed as the proposed liquidator. GSV Ophthalmic Private Limited has not conducted any business since its inception, which appears to be the primary reason for this decision. GKB Ophthalmics shareholders have already approved this move via postal ballot, in compliance with regulatory requirements.
 no imag found
11Oct 25
GKB Ophthalmics Reduces Production by 50% Amid Market Challenges, Wins Export Excellence Award
GKB Ophthalmics has reduced production at its Goa plant by 50% due to sluggish market demand and cessation of US export orders. The company is gradually releasing temporary workers to reduce labor costs. Despite these challenges, GKB Ophthalmics received an Export Excellence Award in the 'Hard Resilent Lenses' category from the Plastic Export Promotion Council, securing first position.
 no imag found
22Sept 25
GKB Ophthalmics Initiates Voluntary Liquidation of Material Subsidiary GSV Ophthalmics
GKB Ophthalmics' Board approved voluntary liquidation of its material subsidiary, GSV Ophthalmics, under the Insolvency and Bankruptcy Code, 2016. GSV, despite being material, had no business operations and primarily earned passive income. The liquidation will impact consolidated financials through reduced other income. GKB will repay a Rs. 5.00 crore unsecured loan to GSV and expects to recover its 79.54% equity investment after liquidation costs. Shareholder approval will be sought via postal ballot with a September 26 cut-off date, complying with SEBI LODR regulations.
 no imag found
12Sept 25
GKB Ophthalmics Faces Rs 8.82 Crore Recovery Order Amid Ongoing Labour Dispute
GKB Ophthalmics Limited has been directed by the Labour Commissioner to pay Rs 8.82 crore in a labour dispute dating back to 2009. The order, received on September 12, 2023, relates to an award passed by the Industrial Tribunal in 2021. The company plans to challenge this order in the High Court of Bombay at Goa, arguing that crucial factors were not considered in the original award. GKB Ophthalmics does not admit liability and is already contesting the original award through a writ petition.
 no imag found
25Aug 25
Ace Investor Vijay Kedia Weighs In on GKB Ophthalmics Shareholder Controversy
Ace investor Vijay Kedia has commented on a recent incident involving GKB Ophthalmics Ltd and a shareholder, Abhishek Kalra. During the company's virtual AGM, Kalra criticized the management for poor stock performance and governance issues, demanding the Managing Director's resignation. Kedia condemned the harsh language used but supported the underlying message, emphasizing the importance of respecting shareholder money and holding incompetent managements accountable. The incident has sparked discussions about shareholder activism and corporate governance in India.
 no imag found
23Aug 25
GKB Ophthalmics Faces Shareholder Criticism at Virtual AGM
GKB Ophthalmics Ltd held its 43rd Annual General Meeting (AGM) virtually on August 21, 2025. The meeting was marked by controversy when shareholder Abhishek Kalra, owning one share, verbally attacked the company's management. Kalra criticized Managing Director Krishna Gopal Gupta's performance and demanded his resignation within 10 days. The confrontation occurred against a backdrop of weak stock performance, with shares declining 32.27% over the past year and 18.38% year-to-date. Despite the incident, the AGM proceeded with its agenda, passing several resolutions including financial statement adoption, director re-appointment, and approval of related party transactions. The meeting saw participation from 55 shareholders, with all resolutions passed by the requisite majority.
 no imag found
19Aug 25
Thakkers Group Reports 85% Revenue Surge in Q1, Net Profit Jumps 68%
Thakkers Group Limited, a real estate developer, reported strong Q1 results with total income rising 85.3% to Rs 791.88 lakhs and net profit increasing 68% to Rs 261.20 lakhs year-over-year. Earnings per share improved to Rs 16.50 from Rs 9.82. The company's reserves grew to Rs 5815.20 lakhs, while paid-up equity share capital remained at Rs 158.33 lakhs. However, revenue saw a slight sequential decline from the previous quarter.
 no imag found
GKB Ophthalmics
73.00
-1.85
(-2.47%)
1 Year Returns:+11.42%
Industry Peers
Poly Medicure
1,453.10
(-0.63%)
Tarsons Products
201.08
(+2.29%)
Osel Devices
601.20
(-1.91%)
Laxmi Dental
190.44
(+0.18%)
Fabtech Technologies
152.12
(-0.82%)
Vasa Denticity
373.75
(-1.66%)
Prevest Denpro
416.30
(-0.88%)
Aprameya Engineering
232.20
(-1.82%)
Nureca
254.35
(-2.70%)